0
0
Since this past September, pharmaceutical giant GlaxoSmithKline has argued five Zofran birth defect lawsuits should be dismissed from the litigation because they do not meet discovery deadlines. However, Judge F. Dennis Saylor IV, who is presiding over the litigation, held the cases may proceed.
In 2010, Connie Shatswell got the shock of her life – she was diagnosed with breast cancer. After undergoing chemotherapy, Ms. Shatswell, beat her diagnosis and has lived cancer-free for over six overs. But Ms. Shatwell’s life has not completely returned to normal because the chemotherapy drug used to fight her cancer caused her to suffer permanent hair loss. Ms. Shatswell knew chemotherapy could cause her hair loss, but she had no idea or warning that it would be permanent. The drug used in her treatment, called Taxotere, has been shown to cause alopecia, or permanent hair loss.
Do Hospitals Know The Defective Medical Device Reporting Requirements?
By Andrew Steinberg / 30 November 2016
Hospitals have a responsibility to report any adverse event related to medical devices to the U.S. Food and Drug Administration (FDA), but a recent investigation found many hospitals are unaware of the reporting requirements.
Post-operative infections are one of the most dangerous conditions for patients recovering from recent surgeries. While all operations come with their own risks, more than 800 people allege a heater-cooler device used during their surgeries caused their post-operative infections.
Although healthcare giant Johnson & Johnson (J&J) has maintained its baby powder products are perfectly safe for months, an increasing number of lawsuits allege its products cause ovarian cancer. But J&J’s struggles over baby powder have gone international, with over 20 women in Ireland gearing up to file a lawsuit of their own.
Chronic heartburn can cause a variety of devastating conditions like cancer, but the drugs that treat this condition present risks of their own. Called Proton Pump Inhibitors (PPIs), these drugs work to relieve heartburn by reducing the amount of acid in the stomach; but an increasing number of studies found the medications have dangerous side effects.
Judge In Taxotere Multidistrict Litigation Appoints Plaintiffs’ Steering Committee
By Andrew Steinberg / 25 November 2016
The multidistrict litigation regarding the breast cancer drug Taxotere took a momentous step forward with the appointment of Plaintiffs’ Liaison Counsel and the Plaintiffs’ Steering Committee (PSC). The Chief Judge of the U.S. District Judge for the Eastern District of Louisiana, the Honorable Kurt D. Englehardt, issued an Order on the litigation leadership appointments that will last for one year. After that time, appointees will either be replaced or renewed. For plaintiffs in the litigation, the appointment allows their cases to move forward in their fight to hold the manufacturer, Sanofi-Aventis, responsible.
Johnson & Johnson (J&J) faces thousands of baby powder lawsuits across the country. Currently, cases are being consolidated in various courts, including litigations in New Jersey and Missouri and a coordinated docket in California. Recently added to the list is a new baby powder lawsuit filed in Pennsylvania.
With the recent approval of Olympus America’s new power morcellator device, family members of those who have died from cancer spread by the devices struggle to understand how the device is still on the market.
After its third loss in the baby powder litigation so far this year, healthcare giant Johnson & Johnson (J&J) vowed to appeal all three verdicts and continue to fight other baby powder cancer lawsuits. The company now faces four more lawsuits from Washington and Oregon women claiming the company’s products caused them to develop ovarian cancer.